previous compound ID: 1455 next compound
InChIKey: NDDAHWYSQHTHNT-UHFFFAOYSA-N
SMILES: CC1CC2=CC=CC=C2N1NC(=O)C3=CC(=C(C=C3)Cl)S(=O)(=O)N

biological descriptors:

CFTR relevance: unspecified

Category:
Influence on CFTR function unknown
Order of interaction unknown
subcellular compartment unknown

reference list:

ReferenceID: 53
"GW Carlile" "JW Hanrahan" "SD Macknight" "D Rotin" "J Liao" "B Kus" "E Matthes" "J Goepp" "R Robert" "DY Thomas"

chemical graph of compound 1455





CID is 3702
synonyms found at PubChem are:
indapamide, 26807-65-8, Noranat, Veroxil, Tertensif, Arifon, Fludex, Lozol, Indaflex, Bajaten, Indamol, Tandix, Indapamida, Natrilix, Pressurai, Damide, Ipamix, Indapamidum, Metindamide, Cormil, Indapamidum [INN-Latin], Indapamida [INN-Spanish], 1-(4-Chloro-3-sulfamoylbenzamido)-2-methylindoline, SE-1520, Idapamide, Lozide, Natrix, SE 1520, Apo-Indapamide, Novo-Indapamide, NLozol, Nu-Indapamide, RHC 2555, USV 2555, Indapamide (Lozol), Natrix (TN), Lozol (TN), 4-Chloro-N-(2-methyl-1-indolinyl)-3-sulfamoylbenzamide, Indapamide [USAN:INN:BAN:JAN], Benzamide, 3-(aminosulfonyl)-4-chloro-N-(2,3-dihydro-2-methyl-1H-indol-1-yl)-, EINECS 248-012-7, S-1520, BRN 1604026, C16H16ClN3O3S, 4-chloro-N-(2-methyl-2,3-dihydro-1H-indol-1-yl)-3-sulfamoylbenzamide, 3-(Aminosulfonyl)-4-chloro-N-(2,3-dihydro-2-methyl-1H-indol-1-yl)benzamide, MLS000028554, CHEBI:5893, 4-CHLORO-N-(2-METHYLINDOLIN-1-YL)-3-SULFAMOYLBENZAMIDE, NDDAHWYSQHTHNT-UHFFFAOYSA-N, 4-chloro-N-(2-methyl-2,3-dihydroindol-1-yl)-3-sulfamoylbenzamide, BENZAMIDE, 4-CHLORO-N-(2-METHYL-1-INDOLINYL)-3-SULFAMOYL-, N-(4-Chloro-3-sulfamoylbenzamido)-2-methylindoline, NCGC00018172-03, SMR000058829, Indapamide hemihydrate, DSSTox_CID_24633, DSSTox_RID_80366, DSSTox_GSID_44633, N-[4-Chloro-3-sulfamoylbenzamido]-2-methylindoline, 3-(Aminosulfonyl)-4-chloro-N-(2-methyl-2,3-dihydro-1H-indol-1-yl)benzamide, Benzamide, 3-(aminosulfonyl)-4-chloro-N-(2,3-dihydro-2-methyl-1H-indol-l-yl)-, Indapamide (JAN/USP), SR-01000003079, flupamid, indamide, Indapamid, Hypen SR, Natrilix (TN), Indapamide (USP), FLUBEST, IDAMIDE, (+/-)-Indapamide, Indapamide [USAN:USP:INN:BAN:JAN], RAC INDAPAMIDE, Spectrum_000917, Opera_ID_110, AC1L1GIW, Prestwick3_000220, Spectrum2_000980, Spectrum3_000467, Spectrum4_000017, Spectrum5_000866, S1520, CHEMBL406, D0H8FH, Indapamide (JP17/USP), SCHEMBL41303, BSPBio_000239, BSPBio_002174, KBioGR_000393, KBioSS_001397, 5-20-06-00348 (Beilstein Handbook Reference), MLS001148152, MLS002222229, MLS006011900, ARONIS27110, DivK1c_000508, SPECTRUM1500349, SPBio_001019, BPBio1_000263, GTPL7203, DTXSID7044633, BDBM25901, CTK3J2161, HMS501J10, KBio1_000508, KBio2_001397, KBio2_003965, KBio2_006533, KBio3_001394, MolPort-003-666-209, NINDS_000508, HMS1920F19, HMS2090M16, HMS2091N07, HMS2095L21, HMS2231G13, HMS3259C14, HMS3369J20, HMS3655E06, HMS3712L21, Pharmakon1600-01500349, Indapamide 1.0 mg/ml in Methanol, BCP04140, HY-B0259, KS-00000ZZ7, KS-000048LJ, Tox21_110775, Tox21_113182, Tox21_302687, CCG-40198, CI-045, MFCD00079375, NSC757075, s1730, STL257105, STL455045, AKOS015888148, Tox21_110775_1, AB03037, AC-2073, ACN-029813, API0002990, CS-2245, DB00808, KS-5219, MCULE-1549472772, NC00568, NSC-757075, IDI1_000508, NCGC00018172-02, NCGC00018172-04, NCGC00018172-06, NCGC00018172-08, NCGC00018172-09, NCGC00089727-02, NCGC00089727-03, NCGC00256884-01, AN-14323, CC-29500, CPD000058829, LS-26138, SAM002564214, SC-22596, SBI-0051415.P003, AB0012132, AB2000254, RT-000328, TL8002131, AB00052021, FT-0630528, I0730, ST51015024, Arifon;Fludex;Noranat;Veroxil;Tertensif;Lozol, A23574, D00345, J10257, AB00052021-14, AB00052021-15, AB00052021_16, AB00052021_17, 807I658, C-21015, Indapamide, analytical standard, for drug analysis, I01-0369, J-016554, SR-01000003079-2, SR-01000003079-3, BRD-A95869247-001-04-6, BRD-A95869247-001-14-5, N-[4-Chloro-3-sulfamoylbenzamido]-2- methylindoline, Z2786158257, 4-chloro-N-(2-methylindolin-1-yl)-3-sulfamoyl-benzamide, Indapamide, European Pharmacopoeia (EP) Reference Standard, N-[4-CHLORO-3-SULFAMOYLBENZAMIDOL]-2-METHYLINDOLINE, (4-chloro-3-sulfamoylphenyl)-N-(2-methylindolinyl)carboxamide, Indapamide, United States Pharmacopeia (USP) Reference Standard, NLozol, Arifon, Fludex, Noranat, Veroxil, Tertensif, Indapamide, (+/-)-4-CHLORO-N-(2-METHYL-1-INDOLINYL)-3-SULFAMOYLBENZAMIDE, 3-aminosulfonyl-4-chloro-N-(2,3-dihydro-2-methyl-1H-indol-1-yl)benzamide, 4-chloro-3-aminosulphonyl-N-(2,3-dihydro2-methyl-1H-indol-1-yl)benzamide, 4-Chloro-N-(2-methyl-2,3-dihydro-indol-1-yl)-3-sulfamoyl-benzamide, Indapamide, Pharmaceutical Secondary Standard; Certified Reference Material, 3-(aminosulphonyl)-4-chloro-N-(2-methyl-2,3-dihydro-1H-indol-1--yl)benzamide, 3-(aminosulphonyl)-4-chloro-N-(2-methyl-2,3-dihydro-1H-indol-1-yl)benzamide, 4-chloro-N-(2-methyl-2,3-dihydro-1H-indol-1-yl)-3-sulfamoylbenzenecarboximidic acid, Benzamide, 3-(aminosulfonyl)-4-chloro-N-(2,3-dihydro-2-methyl-1H-indol-1-yl)- (9CI), Benzamide, 3-(aminosulfonyl)-4-chloro-N-(2,3-dihydro-2-methyl-1H-indol-1-yl)-(9CI), 49564-58-1